Watchlist Price Alert

Liminatus Pharma Inc. War... (LIMNW)

NASDAQ: LIMNW · Real-Time Price · USD

0.07

-0.03 (-30.00%)

At close: May 27, 2025, 1:31 PM

Liminatus Pharma Warrants Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2024	Q4 2023	Q1 2023
Period Ending	Mar 31, 2024	Dec 31, 2023	Mar 31, 2023
Net Income	-858.23M	734.64M	-648.72M
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a
Other Working Capital	-270.99M	504.15M	-342.55M
Other Non-Cash Items	130.63M	1.22B	24.94M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	-176.12M	-500.18M	-103.79M
Operating Cash Flow	-903.72M	1.46B	-727.57M
Capital Expenditures	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	248.83M	-11.43B	688.55M
Investing Cash Flow	248.83M	-11.43B	688.55M
Debt Repayment	700M	-744.17M	108.72M
Common Stock Repurchased	n/a	10.66B	-305.01M
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a
Financial Cash Flow	700M	9.91B	-196.29M
Net Cash Flow	45.11M	-337.29M	-235.3M
Free Cash Flow	-903.72M	1.46B	-727.57M